差异化甲状腺癌的手术治疗的核心成果集:德尔菲研究的国际共识
Daniël J van de Berg1,2, Menno R Vriens3, Hanneke M van Santen4,5
1Department of Pediatric Surgery, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Thyroid : official journal of the American Thyroid Association
|November 7, 2025
概括
这项研究建立了差异化甲状腺癌 (DTC) 手术的国际核心结果集 (COS). 共识促进研究和临床实践结果的一致报告,以更好地评估治疗.
科学领域:
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
- 临床流行病学 临床流行病学
背景情况:
- 在差异化甲状腺癌 (DTC) 手术中,关于结果选择和报告的国际共识缺乏,这阻碍了治疗评估.
- 需要一个标准化的核心成果集 (COS),以便在DTC手术研究和临床实践中进行一致的测量和报告.
研究的目的:
- 为分化甲状腺癌 (DTC) 手术开发一个国际核心成果集 (COS).
- 在DTC手术研究和临床实践中标准化结果测量和报告.
主要方法:
- 文献审查,以编制初步结果列表.
- 两轮国际德尔菲进程,涉及125名专家和来自35个国家的7名患者代表.
- 通过国际专家小组会议完成COS.
主要成果:
- 在两轮德尔菲会议后,在17个结果上达成共识.
- 批准了13个关键结果,包括复发,持续性疾病,转移性淋巴结特征,术后胆固醇水平,手术完整性,神经麻,甲状腺缺陷症,并发症率,重新手术,死亡率和生活质量.
- 开发的COS促进了在DTC手术中一致的结果选择.
结论:
- 已经建立了一个关于差异化甲状腺癌 (DTC) 手术的核心结果集 (COS) 的国际共识.
- 这种COS将有助于在临床实践和研究中进行一致和适当的结果选择.
- 未来的步骤包括在COS中定义具体的结果.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
The Thyroid Gland
6.6K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.6K
Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Inflammatory Bowel Disease V: Surgical Management
430
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
430
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634


